Co-Authors
This is a "connection" page, showing publications co-authored by MATTHEW HAROLD KATZ and BRIAN WESTON.
Connection Strength
0.335
-
3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. J Clin Invest. 2022 12 15; 132(24).
Score: 0.055
-
A decade's experience of managing suspected pancreatic adenocarcinoma at a tertiary cancer center. Ann Gastroenterol. 2023 Jan-Feb; 36(1):81-86.
Score: 0.054
-
Management of ampullary adenomas in familial adenomatous polyposis syndrome: 16 years of experience from a tertiary cancer center. Gastrointest Endosc. 2020 08; 92(2):323-330.
Score: 0.045
-
Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer. JCO Precis Oncol. 2019; 3.
Score: 0.043
-
First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol. 2019 Feb; 26(2):619-627.
Score: 0.041
-
Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience. J Gastrointest Surg. 2017 01; 21(1):164-174.
Score: 0.036
-
Prevalence of extra-pancreatic cysts in patients with cystic pancreatic lesions detected by endoscopic ultrasound. Endosc Ultrasound. 2015 Jul-Sep; 4(3):219-24.
Score: 0.033
-
Prolonged endoscopic loop ligation for removal of gastrointestinal tumors. Endoscopy. 2013; 45 Suppl 2 UCTN:E69-70.
Score: 0.028